Clinical Trial

Development of an Integrated Multi-channel Artificial Nose for Cancer Detection (UNos)

Study acronym: UNOS
Completed
View on ClinicalTrials.gov →
Summary
This interventional diagnostic study evaluated a multi-channel artificial nose (UNos) medical device for analysis of exhaled breath in participants with head and neck squamous cell carcinoma and healthy volunteers. Participants underwent a standardized breath sampling procedure, and exhaled air was analyzed using semi-selective sensor arrays to generate quantitative breath pattern signatures. The study evaluated the ability of the device to discriminate cancer participants from healthy controls based on sensor-derived breath profiles.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-10.
Trial Details
NCT Number NCT07419113
Lead Sponsor Institute of Oncology Ljubljana
Conditions Head and Neck Cancer
Enrollment 45 participants
Start Date 2023-02-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-24